Koers Aytu Bioscience Inc OTC Bulletin Board
Aandelen
AYTU
US0547542052
Farmaceutische producten
slotkoers
Andere beurzen
|
||
- USD | - |
Omzet 2024 * | 81,33 mln. 74,99 mln. | Omzet 2025 * | 78,22 mln. 72,13 mln. | Marktkapitalisatie | 17,54 mln. 16,17 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -13 mln. -11,99 mln. | Nettowinst (verlies) 2025 * | 4 mln. 3,69 mln. | EV/omzet 2024 * | 0,22 x |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 0,22 x |
K/w-verhouding 2024 * |
-1,27
x | K/w-verhouding 2025 * |
4,09
x | Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 96,43% |
Recentste transcriptie over Aytu Bioscience Inc
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Joshua Disbrow
CEO | Chief Executive Officer | 49 | 16-04-15 |
Jarrett Disbrow
FOU | Founder | 49 | 16-04-15 |
Mark Oki
DFI | Director of Finance/CFO | 55 | 17-01-22 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Vivian Liu
BRD | Director/Board Member | 62 | 01-07-22 |
Jarrett Disbrow
FOU | Founder | 49 | 16-04-15 |
Joshua Disbrow
CEO | Chief Executive Officer | 49 | 16-04-15 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+40,73% | 739 mld. | |
+32,83% | 598 mld. | |
-6,30% | 353 mld. | |
+15,15% | 318 mld. | |
+4,05% | 285 mld. | |
+15,00% | 240 mld. | |
+9,78% | 210 mld. | |
-5,52% | 206 mld. | |
+6,17% | 164 mld. |
- Beurs
- Aandelen
- Koers AYTU
- Koers AYTU